Outcomes of Autologous Whole Blood Injection for the Treatment of Plantar Fasciitis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2025

Conditions
Plantar Fascitis
Interventions
BIOLOGICAL

Injection of autologous whole blood to the plantar fascia

Patients assigned in this group will have 2 ml of blood withdrawn from a peripheral vein, then mixed with 1 mL Lidocaine 2% for a total of 3mL volume in one syringe. The patient will be asked to lie down in the clinic bed, and the injection will be administered to the plantar fascia by the principal investigator using a sterile technique.

DEVICE

Injection of normal saline to the plantar fascia

This will be the control group receiving sham injection. Patients will have 2 ml of blood withdrawn from a peripheral vein for blinding proposes. They will be asked to lie down on the clinic bed, 1 ml of normal saline will be administered under sterile technique by the principal investigator. The blood that was withdrawn initially will be discarded.

Trial Locations (1)

Unknown

RECRUITING

Sultan Qaboos Univeristy Hospital, Muscat

All Listed Sponsors
lead

Sultan Qaboos University

OTHER